Brief: Oncternal Therapeutics Q2 net income USD -8.966 million
10/08/2023 21:29
Aug 10 (Reuters) - Oncternal Therapeutics Q2 net income USD -8.966 million. * Q2 income from operations USD -9.545 million * Q2 operating expenses USD 9.651 million * Q2 basic EPS USD -0.15
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;